What were Solara Active Pharma Sciences Ltd's latest quarterly results?
Solara Active Pharma Sciences Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +557.1%
- Revenue Growth YoY: +41.9%
- Operating Margin: 14.9%
Solara Active Pharma Sciences Ltd: Stock Analysis & Fundamentals
Updated this weekSolara Active Pharma Sciences Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. ROE: -0.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Solara Active Pharma Sciences Ltd Key Facts
What's Happening
👔Promoter buying — stake up 4.7% this quarter
🌐FII stake decreased 0.7% this quarter
Key Numbers
Current Price
₹572
Market Cap
2.7K Cr
Valuation
N/AOther Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: Solara Active Pharma Sciences Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Solara Active Pharma Sciences Ltd's price-to-book ratio?
Solara Active Pharma Sciences Ltd's price-to-book ratio is 1.6x.
- Price-to-Book (P/B): 1.6x
- Book Value per Share: ₹346
- Current Price: ₹572
Is Solara Active Pharma Sciences Ltd a fundamentally strong company?
Solara Active Pharma Sciences Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 5.0%
Is Solara Active Pharma Sciences Ltd debt free?
Solara Active Pharma Sciences Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹687 Cr
What is Solara Active Pharma Sciences Ltd's return on equity (ROE) and ROCE?
Solara Active Pharma Sciences Ltd's return ratios over recent years
- FY2024: ROCE -9.0%
- FY2025: ROCE 6.0%
- FY2026: ROCE 5.0%
Is Solara Active Pharma Sciences Ltd's cash flow positive?
Solara Active Pharma Sciences Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹153 Cr
- Free Cash Flow (FCF): ₹54 Cr
What is Solara Active Pharma Sciences Ltd's dividend yield?
Solara Active Pharma Sciences Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹572
Who holds Solara Active Pharma Sciences Ltd shares — promoters, FII, DII?
Solara Active Pharma Sciences Ltd's shareholding pattern (May 2026)
- Promoters: 42.0%
- FII (Foreign): 11.3%
- DII (Domestic): 3.8%
- Public: 42.9%
Is promoter holding increasing or decreasing in Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 42.0% (May 2026)
- Previous Quarter: 42.0% (Mar 2026)
- Change: 0.00% (stable)
Is Solara Active Pharma Sciences Ltd a new momentum entry or an established outperformer?
Solara Active Pharma Sciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Solara Active Pharma Sciences Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Solara Active Pharma Sciences Ltd may be worth studying
- Cash flow is positive — CFO ₹153 Cr
What is the investment thesis for Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd investment thesis summary:
What is the future outlook for Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.